BWAY Stock Analysis: Buy, Sell, or Hold?
BWAY - Brainsway Ltd. American Depositary Shares
$23.38
-0.67 (-2.79%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 10, 2026
Get Alerted When BWAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BWAY shows positive signals but monitor for confirmation. Market pricing in 1.0% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: BWAY shows positive signals but monitor for confirmation. Market pricing in 1.0% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$13.31
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$8.26
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BWAY is currently trading at $23.38, which is considered slightly high relative to its 30-day fair value range of $20.35 to $24.37. The stock's valuation (Forward PE: 85.5) is in line with its historical norms (83.0). At these levels, the market is pricing in 1.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, BWAY is in a strong uptrend. Immediate support is located at $21.93, while resistance sits at $25.65.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.33 (+12.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BWAY is in a strong uptrend. Immediate support is located at $21.93, while resistance sits at $25.65.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.33 (+12.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$20.35 -
$24.37
Company Quality Score
61/100
(BUY)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
65.0%
All Signals
- NEUTRAL: Options fairly priced (IV 50th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($26.33)
- NEUTRAL: Market pricing in 1.0% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$20.35 -
$24.37
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
±$3.06
(13.1%)
Support & Resistance Levels
Support Level
$21.93
Resistance Level
$25.65
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
85.55
Wall Street Target
$26.33
(+12.6%)
Revenue Growth (YoY)
28.7%
Earnings Growth (YoY)
100.0%
Profit Margin
12.7%
Valuation Premium vs History
+1.0% premium
PE vs Historical
85.6 vs 83.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.0%
(market-implied from PE analysis)
1-Year Target
$23.61
(+1%)
2-Year Target
$23.85
(+2%)
3-Year Target
$24.09
(+3%)
3-Yr Target (if PE normalizes)
(PE: 86→83)
PE COMPRESSION
$23.37
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 85.5, Growth: 57.7%)
$78.91
(+238%)
Base:
(SPY PE: 22.3, Growth: 57.7%)
$20.57
(-12%)
Bear:
(PE: 19.0, Growth: 57.7%)
$17.48
(-25%)
📈
Valuation based on Current Earnings
Trailing PE: 77.22 | Current EPS (TTM): $0.32
Bull Case
$23.21
(-1%)
Analyst growth -14.6%, PE expands to 84.9
Base Case
$21.10
(-10%)
Market implied -14.6%, PE stable at 77.2
Bear Case
$16.80
(-28%)
Severe decline -20.0%, PE contracts to 65.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: February 01, 2026 7:18 PM ET
Data refreshes hourly during market hours. Next update: 8:18 PM
Data refreshes hourly during market hours. Next update: 8:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BWAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$370 | 54 HOLD |
